LYNX1 CAPITAL MANAGEMENT LP – Kinnate Biopharma Inc. Transaction History
LYNX1 CAPITAL MANAGEMENT LP portfolio value:
$20.01M
portfolio value
LYNX1 CAPITAL MANAGEMENT LP quarter portfolio value change:
-5.23%
quarter
Kinnate Biopharma Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | 0.00% | 0 shares | -1.10M | $11.95 | 1.67M | |
| Q2 2022 | share | Increase | +141.83% | 982.16K shares | 13.32M | $12.61 | 1.67M |
| Q1 2022 | share | Increase | 0.00% | 692.50K shares | 7.79M | $11.26 | 692.50K |